Sell: CVS Health Corporation (CVS)
From The Complete Investor
Updated from Investment Digest 761, September 17, 2014
We are selling CVS Health Corporation (CVS). The company has been losing market share in its pharmacy benefit management (PBM) business, which results in both fewer prescriptions filled by CVS and less floor traffic generating sales of all the non-drug items CVS sells.
We expect the stock can maintain growth in the high single digits and that CVS, which pays high corporate taxes, might benefit from a Trump tax cut, but there are stronger, more levered growth stocks to choose from.
Stephen Leeb, PhD. And Genia Turanova, The Complete Investor, www.completeinvestor.com, 866-833-2070, December 2016